Akebia Gains FDA Approval of Vafseo Tablets for Treatment of Anemia
Akebia Therapeutics has declared that the US Food and Drug Administration (FDA) has approved Vafseo (vadadustat) Tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults.
Vafseo Tablets | 28/03/2024 | By Manvi | 337
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy